Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prestige Consumer Healthcare (PBH) Invested Capital (2016 - 2025)

Prestige Consumer Healthcare has reported Invested Capital over the past 16 years, most recently at $2.9 billion for Q4 2025.

  • Quarterly results put Invested Capital at $2.9 billion for Q4 2025, up 59.64% from a year ago — trailing twelve months through Dec 2025 was $2.9 billion (up 59.64% YoY), and the annual figure for FY2025 was $2.8 billion, up 1.67%.
  • Invested Capital for Q4 2025 was $2.9 billion at Prestige Consumer Healthcare, up from $1.8 billion in the prior quarter.
  • Over the last five years, Invested Capital for PBH hit a ceiling of $3.1 billion in Q3 2022 and a floor of $1.4 billion in Q2 2021.
  • Median Invested Capital over the past 5 years was $2.8 billion (2024), compared with a mean of $2.3 billion.
  • Biggest five-year swings in Invested Capital: skyrocketed 136.92% in 2021 and later crashed 51.46% in 2023.
  • Prestige Consumer Healthcare's Invested Capital stood at $1.5 billion in 2021, then grew by 10.9% to $1.7 billion in 2022, then dropped by 5.27% to $1.6 billion in 2023, then increased by 11.88% to $1.8 billion in 2024, then surged by 59.64% to $2.9 billion in 2025.
  • The last three reported values for Invested Capital were $2.9 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.9 billion (Q2 2025) per Business Quant data.